http://www.envita.com/conditions-we-treat/lymedisease/ Chronic Lyme disease is a complex multi-system, multi-neuroendocrine, multi-infectious disease that mimics over 360 different inflammatory diseases. Get the best personalized Lyme disease treatment by contacting Envita Medical Centers today.

1. Breakthrough Understanding of Lyme Disease and Lyme Disease
Treatment
Lyme Disease Misunderstood Leading to Unsatisfactory Lyme Disease Treatment Protocols
Lyme disease, often referred to as “the great imitator” is certainly one the most misunderstood
and widely growing diseases within our borders. Because its symptomology resembles that of
so many other illnesses and because the conventional medical community continues to be
somewhat ignorant, afflicted patients are denied the Lyme disease treatment necessary to
regain their health. Because Lyme disease is so blatantly misunderstood, routine treatment
typically lasts a mere 4-6 weeks, with extensive treatment rendered unnecessary. As a result, a
majority of insurance companies decline to approve appropriate treatment and residual
Borrelia reemerges , so that patients often relapse with Lyme or dismally, Lyme Disease
Complex. To further cloud the issue, most patients diagnosed with Lyme disease are unaware of
the full “complex” of co-infections and neurotoxins that dwell in their system – dooming the
possibility of prescription medication as a viable, solitary Lyme disease treatment.
Before We Can Talk About Lyme Disease Treatment, We Must Understand What Lyme
Disease Complex Is

2. In the arena of conventional medicine protocols, there is often conflicting opinion as to
whether chronic Lyme disease is truly an authentic disease at all. Others recognize that patients
certainly do suffer with Lyme disease symptoms associated with Borrelia contracted through
tick bites. Unfortunately, most care providers do not have true LLMDs (Lyme Literate Doctors)
on board who recognize the complexity, severity, and difficulty that is associated with Lyme
disease treatment. To heighten understanding, the following represent the most common
infections that assume a role in Lyme disease. They are all potential contributors to what Envita
Medical Centers calls Lyme disease complex – a confluence of infections that may
simultaneously include bacterial, viral, parasitic, and fungal co-infections that all require specific
Lyme disease treatment and protocol customization to heal patients in the long term.
1. Borrelia (B. burgdorferi) – The premier infection found in Lyme disease patients which is
often considered to be the tick-borne variety that produces Lyme disease itself. While it
is a major contributor, Borrelia makes up but one of the numerous infections that create
Lyme disease so that adequate treatment becomes an enormous challenge.
2. Bartonella – Bartonella henselae is the causative agent of the undesirable cat-scratch
fever, endocarditis, and culprit promoting several other serious diseases in humans.
These bacteria comprise one of Lyme disease Complex’s most ardent co-infections. The
bacteria are transferred by fleas, body lice, and ticks – with ticks being the greatest
source of human bartonellosis infection, often accompanied by Lyme disease. Sand flies
carry the bacteria in Peru’s Andes Mountains, Colombia, and Ecuador while human body
lice carriers appear in droves throughout the world. The European sheep tick is a known
carrier and five different species of Bartonella have been detected in nearly 20 percent
of I. Pacificus ticks collected in California.
3. Epstein-Barr (HHV-4) – This is a common human herpes virus that will infect virtually the
entire population at some point in their lifetimes. It is possible for EBV to remain
dormant in the body throughout the entire length of an individual’s life span. Typically,
the disease is transmitted via saliva and takes thirty to forty-five days to present with
symptoms – if it ever does at all. During this juncture, the host is most likely to be
contagious. However, when these infections endure as seen in chronic fatigue patients it
becomes essential to test for chronic Lyme disease complex and its co-infections and
immunity. Lyme disease treatment is warranted as multiple infections can often awaken
dormant infections such as Epstein-Barr.
4. Cytomegalovirus (CMV) - Approximately 80 percent of adults our country are infected
with cytomegalovirus (CMV). It is a recognized member of the herpes family and shares
the irascible ability to remaining alive, yet dormant, in the human body for the life of its
human host. Rarely does CMV become active unless the immune system is infiltrated –

3. as it can easily be (and most often is) with Lyme disease infections overwhelming the
immune system.
5. Babesiosis- Intraerythrocytic parasite Babesia microiti causes Babesiosis, an infection
that festers inside red blood cells. It is transmitted by the particular tick that transmits B.
burgdorferi, the causative agent of Lyme disease. Forty one percent of patients
combating Babesia develop serious complications which may include acute respiratory
failure, disseminated intravascular coagulation, congestive heart or renal failure.
Complex babesiosis is regularly linked with the presence of severe anemia and high
parasitaemia levels. Chronic babesia has been known to promote cardiovascular, kidney,
and liver problems in patients. Babesiosis is clearly a detrimental component of Lyme
disease. It requires testing and, if advised, covered with a comprehensive Lyme disease
treatment.
6. Human Herpes Virus 6 – Lyme disease complex may also include human herpes virus 6
(HHV-6) has undisputedly become one of the most widespread members of human
herpes viruses and presents in two related variants: HHV-6A and HHV-6B. HHV-6 is
charted to attack specific cells including but not limited to CD 4 lymphocytes, NKTs,
oligodedrocytes, CD8 cells, and microglial cells. To summarize, this virus is immune
suppressive and also activates other viruses in the process. While HHV-6 can remain
latent for long periods of time, it can surely reactivate and cause infection quickly. A
comprehensive Lyme disease treatment must be implemented in an effort to combat
HHV-6 and other Lyme disease complex infections.
7. Ehrlichiosis - Ehrlichiosis is a resistant Lyme disease co-infection caused by rickettsial-
type (specific bacteria) organisms that comes in two specific forms; Human Monocytic
Ehrlichiosis (HME) and Human Granulocytic Ehrlichiosis (HGE). In a plethora of cases,
Ehrlichiosis is self-limiting and not fatal with death rates in large, unselected series
ranging from 1 to 8 percent [3,6-8]. This contrasts sharply with the high death rate in
patients who are immunocompromised. Characteristically, however, Lyme disease
patients reside in the dangerous “immunocompromised” category. That is why it is
essential for patients to receive an aggressive and comprehensive Lyme disease
treatment plan.
8. Chlamydia pneumonia - Chlamydophila pneumoniae (formerly known as Chlamydia
pneumoniae or CP) are bacteria which infect humans and can result in pneumonia. They
are a type of Chlamydia . Chlamydophila pneumoniae has a complex life cycle and needs
to compromise another cell to reproduce itself. The disease often emerged as a
respiratory infection, residing relatively unnoticed in the body and spread with abandon

4. to infect other tissues as nerves, brain, muscles, blood vessels and even cells of the
immune system, the macrophages. CP itself produces at least two toxic substances that
prompt tissue destruction and inflammatory burden, as well as a chronic immune
activation to invade the body with a toxin load. CP survive in the cell similarly as a
parasite sucks energy and continue to reproduce themselves. Therapy, however, must
be administered effectively until CP is destroyed in all three stages, which halts re-
infection and is a critical part of Lyme disease treatment in cases where CP is present.
9. Candida - The most common organism implicated in fungal infections is the ubiquitous
Candida, which is found in the human digestive tract, mouth, and genital region
(Eggiman P et al 2003). Under normal circumstances, levels of Candida are reigned in by
beneficial bacteria. However, if the bacteria-fungus balance is upset, by the use of
antibiotics for example, or if the immune system is compromised, an overabundance of
Candida can occur, resulting in infection. As the immune system is always compromised
by the presence of chronic Lyme disease - the presence of Candida must be aggressively
minimized in a comprehensive Lyme disease treatment.
As blatant as the above maladies seem, it is equally reasonable to point out that only 13% of
infections that exist around the globe have actually been identified. Among these are zoonotic
infections (those received from animals) - making Lyme disease treatment among the most
complex to approach.
The Reality of Lyme Disease and Lyme Disease Treatments That Can Actually Work
If Lyme disease is detected early, it can be treated rather well with a realistic course of
antibiotics. However, in a huge majority of cases, Lyme disease is not addressed by either the
patients or their physicians at its onset - if they do at all. For patients who have had Lyme
disease for more than a year, significantly more aggressive Lyme disease treatment must be
authorized.
The standard prescription of antibiotics is categorically deemed insufficient when treating Lyme
disease complex or as a sole Lyme disease treatment. Antibiotics do not help the body to
destroy the mycotoxins or BLP (bacteria lipoprotein neurotoxins) caused by Borrelia, nor are
they effective in treating the various viral, fungal, and parasitic co-infections attendant to Lyme
disease. These co-infections are existent in some random combination in virtually every Lyme
disease patient and must be dealt with in any worthy Lyme disease treatment.
To be clear, is not uncommon to notice four or more combinations of infections in chronic Lyme
disease patients. Often months, or perhaps even years of treatment are incumbent to remove
the stubborn Borrelia from the body – not to mention the multitudes of other attackers
liberated by the presence of Lyme disease complex in the body. Chronic Lyme disease
treatment requires an organized/customized program that includes reestablishing immune
function and status for patients. Simply administering medication will not be successful and can
even complicate matters for the worse. With a degree of certainty, practitioners who attempt

5. to treat patients using anti-malaria drugs such as plaquenil, routinely fail as they do not address
the immune system.
Chronic Lyme Disease Awareness and Effective Lyme Disease Treatment
Treatment of Lyme disease must be aimed at more than just the infections. Reducing
inflammation, supporting the immune system, detoxification of BLP’s, and addressing hormone
deficiencies are in sync with a comprehensive chronic Lyme disease treatment plan. If patients
are taking other medications or pain reducers, a delicate approach is needed to transition them
to improved quality of life. Moreover, when patients indicate they have Lyme disease, or Lyme
disease doctors assess patients - it is a recognition that they are dealing with a combination of
infections, as well as an immune compromised state. While the infections present may vary
from case to case, the dilemma is Lyme disease complex, or "a combination of infections”.
Envita’s Experience is the Difference for Lyme Disease Patients and Life-changing Lyme
Disease Treatment
Envita has worked in the field of Lyme disease research and Lyme disease treatment for nearly
a decade. Our experiences have prompted more efficient, effective progress in Lyme disease
treatment. At Envita, we address and examine all factors of Lyme disease, assuming that
handling Lyme’s co-infections are just as critical as direct treatment of the primary disease.
Understanding the concept of co-infections and body’s homeostasis imbalances is the reason
why we name it Lyme disease complex and why Envita leads the all nations in effective Lyme
disease treatment.
To further complicate matters, many Lyme disease infections live within the red and white
bloods cells making them very stealth and expectedly, extremely difficult to treat. They can
deter the body's immune defenses and reproduce within the healthy cells. Envita takes
advantage of special shuttling agents to effectively address and treat these pervasive infections.
Lyme Disease Treatment and Complications of Lyme Disease
There has been much discussion about Bioflim communities that protect the infections from
the absolution of medications. In many cases these Biofilm communities must be stripped and
diminished through proper treatment and lifestyle changes.
Another scenario worthy of consideration, as it pertains to Lyme disease treatment, is self-
synergistic replication. In this situation, many infections can communicate with and embellish
or activate, the replication of other viruses already present in the body. All the while, the
patient must engage numerous symptoms that may present as digestion problems, cognitive
difficulties, chronic pain, sleep deprivation, and hormonal imbalances - just to list a few.
Does Chronic Lyme Disease Exist and is Lyme Disease Treatment Necessary
Lyme disease does undeniably have status. And even though many researchers will say the
patient really doesn’t have Lyme disease in the classical laboratory form - patients still often

6. suffer duress from a combination of the infections we mentioned earlier - and they need to all
be treated simultaneously to really provide effective and sustained relief for patients.
It is also of value to realize that many laboratory tests provide false negatives indicating the test
comes back negative when the patient actually has an infection(s) present. Some of the most
common reasons are immune systems that are frequently too weak to mount a proper
antigen test. However, if an immune system challenge is conducted, one may see a positive test
return for these patients. Additionally, many of these infections do live intra-cellularly and as a
result return with false negative results.
At Envita, we have instituted a strong combination of tests to identify specific immunological
factors and a comprehensive clinical overview to help patients find and treat all the factors of
the Lyme Disease complex.
Envita’s Approach to Tackling Lyme Disease and Identifying the Ideal Lyme Disease Treatment
for Each Patient
As Lyme disease is so complex, extensive and comprehensive Lyme disease treatment is
ostensibly vital. At Envita, Lyme disease treatments are not limited to antibiotics, rather
administered in conjunction with aggressive natural therapies from all over the world.
As part of our Disease Solutions Program®, we take an integrative approach to Lyme disease
treatment, utilizing anti-viral, anti-parasitic, and anti-fungal approaches - depending on the co-
infections and symptoms present in each affected patient. By addressing all Lyme disease
complex factors, we achieve significantly better results with our incomparable Lyme disease
treatments.
We implement innovative treatments to help patients achieve full comprehension of their
disease, thereby providing them with the ability to turn the corner. Our intense approach to
treatment helps speed healing time, increase quality of life, and minimize the recurrence of
Lyme disease. To learn more about our Lyme disease treatment protocols or more about Lyme
disease in general, please contact us at Envita Medical Centers today.